Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Mar 2016 Evaluation of a Single Metastasis in Metastatic Prostate Cancer Genitourinary cancers - Translational research
15 Mar 2016 EMA Reviews PI3K Inhibitor Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
14 Mar 2016 FDA Expands Use of Crizotinib in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Mar 2016 Atezolizumab in Patients With Locally Advanced and Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
08 Mar 2016 Launch of EMA’s Priority Medicines Scheme Bioethics, legal and economic issues
08 Mar 2016 ESMO Open Press Release: High White Blood Cell Ratio Linked to Recurrence Risk in Early Stage Breast Cancer Breast cancer
04 Mar 2016 ESMO is Proud That Charité Connects the Patient Guides to the Clinic’s Website
03 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
02 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Trifluridine/Tipiracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
01 Mar 2016 ESMO mourns the loss of Dr. Holbrook Kohrt
01 Mar 2016 EMA Recommends Extending Indications for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
29 Feb 2016 EMA Recommends Extending Indications for Afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Feb 2016 EMA Recommends Extending the Use of Nivolumab Genitourinary cancers - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
25 Feb 2016 US FDA Seeks Support for the National Cancer Moonshot Initiative Bioethics, legal and economic issues
24 Feb 2016 US NCI to Overhaul NCI-60 Tumour Cell Lines Translational research